Showing 1-10 of 3104 results for "".
Spirituality and Spiritual Care of People With Chronic Neurologic Illness
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/spirituality-and-spiritual-care-of-people-with-chronic-neurologic-illness/35444/Despite the spiritual challenges of living with neurologic illness, interventions are available to help ameliorate distress related to existential issues, self-image concerns, conception of personal identity, interpersonal relationships, and grief.Understanding Dystonia: A Practical Approach to Diagnosis and Management
https://practicalneurology.com/diseases-diagnoses/movement-disorders/understanding-dystonia-a-practical-approach-to-diagnosis-and-management/49157/Clinical history helps corroborate the diagnosis of dystonia and provides clues to its etiology; however, the diagnosis rests on clinical examination, because no gold standard laboratory or imaging tests are available.Fluid Biomarkers in Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/fluid-biomarkers-in-multiple-sclerosis/36255/Fluid biomarkers may allow for improvement in diagnosis, prognostication, and monitoring of disease activity and treatment response in multiple sclerosis while reducing reliance on imaging.- Ira M. Turner, MDhttps://practicalneurology.com/profiles/ira-m-turner-md/Lb06rq/
An Exclusive Peer Dinner with Gil I. Wolfe MD, FAAN, Discussing Advancing Treat-to-Target Care in Generalized Myasthenia Gravis
https://practicalneurology.com/live-events/an-exclusive-peer-dinner-with-gil-i-wolfe-md-faan-discussing-advancing-treat-to-target-care-in-generalized-myasthenia-gravis/56668/Through live expert discussion, examine gMG diagnosis, standardized assessment, treat-to-target care, and the integration of FcRn-directed therapy.Location: New York, New York, United StatesDate: October 10, 2026; 05:00 PM - 07:00 PM ETAdvancing Treat-to-Target Care in Generalized Myasthenia Gravis: Earlier Diagnosis, Standardized Assessment, and Precision Use of FcRn-Directed Therapy
https://practicalneurology.com/live-events/advancing-treat-to-target-care-in-generalized-myasthenia-gravis-earlier-diagnosis-standardized-assessment-and-precision-use-of-fcrn-directed-therapy/56674/Through live expert discussion, examine gMG diagnosis, standardized assessment, treat-to-target care, and the integration of FcRn-directed therapy.Location: Atlanta, Georgia, United StatesDate: October 24, 2026; 06:30 PM - 08:30 PM ET- Catherine Chu, MD, to Lead Pediatric Neurology at Kennedy Krieger and Johns Hopkinshttps://practicalneurology.com/news/catherine-chu-md-to-lead-pediatric-neurology-at-kennedy-krieger-and-johns-hopkins/2475483/Catherine Chu, MD, MA, MMSc, has been named Vice President of Child Neurology of the Kennedy Krieger Institute and will also serve as Director of the Division of Pediatric Neurology and the John M. Freeman Pediatric Epilepsy Center at Johns Hopkins Children’s Center. According to a statement rele
- Award Recipients Recognized at 2025 International MDS Conferencehttps://practicalneurology.com/news/award-recipients-recognized-at-the-2025-international-congress-of-parkinsons-disease-and-movement-disorders/2483939/The International Parkinson’s Disease and Movement Disorders Society (MDS) has recognized recipients of the 2025 MDS Awards. The awards honor professionals in the field who are elevating care for movement disorders through their contributions to research, scholarship, and clinical work. The award
- Remembering Ronald DeVere, MD, FAANhttps://practicalneurology.com/news/remembering-ronald-devere-md-faan/2470936/Ronald DeVere, MD, FAAN, Practical Neurology Editorial Advisory Board member and former Editor of the Dementia Insights column, passed away on May 8, 2024, at age 80. Dr. DeVere served as the Director of the Taste & Smell Disorders Clinic and the Alzheimer Disease & Memory Disorder
- CTAD 2025 Honors Takeshi Iwatsubo, MD, PhD with Lifetime Achievement Awardhttps://practicalneurology.com/news/ctad-2025-honors-takeshi-iwatsubo-md-phd-with-lifetime-achievement-award/2484692/Takeshi Iwatsubo, MD, PhD was recognized at the 18th annual Clinical Trials on Alzheimer’s Disease (CTAD) conference as the recipient of this year’s Lifetime Achievement Award in Alzheimer’s Disease Therapeutic Research. The award celebrates Dr. Iwatsubo’s decades of foundational work in Alzheime
- Prev
- Next